Phase 1B Study of RiVax, a Vaccine to Prevent the Toxic Effects of Ricin
Clinical trial NCT00812071 · COMPLETED
Trial details
- NCT number
- NCT00812071
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2012-01-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.